JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Monitoring of Cerebral Blood Flow Autoregulation Using Near Infrared Spectroscopy

Completed

Conditions: Cardiacsurgery

First Posted Date: 2008-10-09

Last Posted Date: 2017-08-22

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 225

Registration Number: NCT00769691

Locations: 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States

Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary Disorder

Not Applicable

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Interventions: Behavioral: Home Automated Telemanagement (HAT)

First Posted Date: 2008-09-15

Last Posted Date: 2023-10-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 280

Registration Number: NCT00752531

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Airway Pressure Release Ventilation in Acute Lung Injury

Not Applicable

Terminated

Conditions: Mechanical Ventilation
Acute Lung Injury
Acute Respiratory Distress Syndrome

Interventions: Device: Conventional MV
Device: APRV

First Posted Date: 2008-09-10

Last Posted Date: 2017-05-15

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 2

Registration Number: NCT00750204

Locations: 🇺🇸
Johns Hopkins Hospital Medical Intensive Care Unit, Baltimore, Maryland, United States

Effects of Transcranial Magnetic Stimulation to the Cerebellum on Cognition

Not Applicable

Completed

Conditions: Cognitive Performance

Interventions: Device: Cerebellar transcranial magnetic stimulation

First Posted Date: 2008-08-25

Last Posted Date: 2018-08-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 17

Registration Number: NCT00740701

Locations: 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions

Phase 4

Completed

Conditions: Arthroplasty, Replacement, Hip

Interventions: Drug: CHG 2% w/v and IPA 70% v/v
Drug: Iodophor 0.7% and IPA 74% w/w

First Posted Date: 2008-08-21

Last Posted Date: 2013-07-10

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 20

Registration Number: NCT00739583

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy

Phase 2

Completed

Conditions: Prostate Cancer
Erectile Dysfunction

Interventions: Drug: Erythropoietin (EPO)
Drug: Placebo

First Posted Date: 2008-08-20

Last Posted Date: 2021-04-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 56

Registration Number: NCT00737893

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Diagnostic Accuracy of Multi-Detector Spiral Computed Tomography Angiography Using 64 Detectors

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Other: Multidetector Computed Tomography - 64 detectors

First Posted Date: 2008-08-20

Last Posted Date: 2008-08-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 405

Registration Number: NCT00738218

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

Recruiting

Conditions: Heart Failure, Congestive
Death, Sudden, Cardiac
Arrhythmia
Cardiomyopathies

First Posted Date: 2008-08-13

Last Posted Date: 2024-01-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1500

Registration Number: NCT00733590

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

and more 1 locations

A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy

Phase 2

Completed

Conditions: Lumbosacral Radiculopathy

Interventions: Drug: etanercept
Drug: normal saline
Drug: methylprednisolone

First Posted Date: 2008-08-12

Last Posted Date: 2012-10-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 84

Registration Number: NCT00733096

Locations: 🇺🇸
Walter Reed Army Medical Center, Washington, District of Columbia, United States
🇺🇸
Womack Army Medical Center, Fort Bragg, North Carolina, United States

The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy

Phase 1

Completed

Conditions: Milk Allergy

Interventions: Drug: Milk Protein Extract Immunotherapy goal of 4mg/day
Drug: Milk Powder Immunotherapy goal dose 1000mg/day
Drug: Milk Protein Extract Immunotherapy goal of 7mg/day
Drug: Milk Powder Immunotherapy goal dose 2000 mg/day

First Posted Date: 2008-08-12

Last Posted Date: 2017-05-15

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT00732654

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Duke University, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy